Barbara E Bierer

Barbara Emily Bierer, MD

Professor of Medicine (Pediatrics), HMS
Member, HMS Center for Bioethics

Barbara Bierer, MD is a Professor of Medicine (Pediatrics) at Harvard Medical School (HMS), and a hematologist/oncologist at the Brigham and Women's Hospital (BWH). She received her MD from HMS. She is the director of the Regulatory Foundations, Law and Ethics Program of the Harvard Catalyst, the Harvard Clinical and Translational Science Award, and the director of regulatory policy, SMART IRB. Dr. Bierer co-founded and now leads the Multi-Regional Clinical Trials Center of BWH and Harvard (MRCT Center), a University-wide and collaborative effort to improve the ethics, conduct, and regulatory environment for multi-site, multi-national clinical trials. She is a co-founder of COVID-19 Collaboration Platform, a platform for cooperation in research. In 2017, the MRCT Center launched the non-profit Vivli, a global clinical research data sharing platform. From 2003-2014, she served as Senior Vice President, Research, at BWH and was the institutional official for human subjects and animal research, for biosafety and for research integrity at the BWH. She initiated the Brigham Research Institute and the Innovation Hub (iHub), a focus for entrepreneurship and innovation. Dr. Bierer established and directed the Center for Faculty Development and Diversity at the BWH; for these efforts, she was the first recipient of the HMS Harold Amos Faculty Diversity Award.

Publications View
Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines.
Authors: Authors: Niemeyer CM, Sieff CA, Mathey-Prevot B, Wimperis JZ, Bierer BE, Clark SC, Nathan DG.
Blood
View full abstract on Pubmed
The biologic roles of CD2, CD4, and CD8 in T-cell activation.
Authors: Authors: Bierer BE, Sleckman BP, Ratnofsky SE, Burakoff SJ.
Annu Rev Immunol
View full abstract on Pubmed
Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation.
Authors: Authors: Bierer BE, Emerson SG, Antin J, Maziarz R, Rappeport JM, Smith BR, Burakoff SJ.
Transplantation
View full abstract on Pubmed
Expression of CD5 regulates responsiveness to IL-1.
Authors: Authors: Nishimura Y, Bierer BE, Burakoff SJ.
J Immunol
View full abstract on Pubmed
The interaction of CD2 with its LFA-3 ligand expressed by autologous erythrocytes results in enhancement of B cell responses.
Authors: Authors: Virella G, Rugeles MT, Hyman B, La Via M, Goust JM, Frankis M, Bierer BE.
Cell Immunol
View full abstract on Pubmed
Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
Authors: Authors: Bierer BE, Peterson A, Gorga JC, Herrmann SH, Burakoff SJ.
J Exp Med
View full abstract on Pubmed
T cell adhesion molecules.
Authors: Authors: Bierer BE, Burakoff SJ.
FASEB J
View full abstract on Pubmed
Interaction of CD2 with its ligand, LFA-3, in human T cell proliferation.
Authors: Authors: Bierer BE, Barbosa J, Herrmann S, Burakoff SJ.
J Immunol
View full abstract on Pubmed
Phenotypic and functional characterization of human cytolytic T cells lacking expression of CD5.
Authors: Authors: Bierer BE, Nishimura Y, Burakoff SJ, Smith BR.
J Clin Invest
View full abstract on Pubmed
Expression and function of a CD5 cDNA in human and murine T cells.
Authors: Authors: Nishimura Y, Bierer BE, Jones WK, Jones NH, Strominger JL, Burakoff SJ.
Eur J Immunol
View full abstract on Pubmed